Roche is a leading healthcare company that has for over 100 years been active in the discovery, development, manufacture and marketing of healthcare solutions. Our products and services address prevention diagnosis and treatment of diseases, thus enhancing well-being and quality of life.

Bedoukian Research, Inc. is a 100% family owned company that provides world-class technical support and customer service. Our company was founded in 1972 to fill a niche as a supplier of high quality specialty aroma molecules. Today, we offer more than 350 high impact fragrance and flavor ingredients, while providing custom manufacturing services to the pharmaceutical and specialty chemical industries. We strive to minimize our impact on the environment, improve our processes and efficiency, and of course, to innovate our next exciting high impact ingredients. Our employees are our greatest resource, and it is their personal involvement in these goals that leads to our industry leading reputation for quality and service. To learn more about Bedoukian Research, please visit us at bedoukian.com.

Grant Industries engages in the research, development, manufacturing, and marketing of textile, cosmetic, and performance specialty chemicals. We serve all major global cosmetic markets and are known for our award-winning products, cutting-edge research and personalized customer care. Our dedication to product performance and customer support makes us the ideal source for state-of-the-art ingredients to improve your product's skin feel. Our main product categories include: polysilicone-11 elastomer gels, silicone/active powders, microsphere powders, surfactants, UV dispersions, specialty silicone fluids and formulated cosmetic ingredients. Additional information on the company and its products are available on the web site grantinc.com Technical Support? [email protected]

Family owned and operated since 1840, Palmer’s is one of the longest standing proprietors of skin and hair care products in the world. Our commitment to quality has made Palmer’s a trusted household name, used by families for generations. We are committed to choosing what’s real, using natural, raw ingredients in our products. As members of the World Cocoa Foundation and Global Shea Alliance, Palmer’s helps empower farmers & communities to create and promote healthy, sustainable production from farm to bottle.

Phathom Pharmaceuticals (Nasdaq: PHAT) is a biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid. We are a team of highly driven pharmaceutical professionals who are passionate about our mission to address unmet needs for patients and improve their quality of life. By ensuring all voices are heard, holding ourselves accountable to be equitable and just, and authentically supporting the people and communities impacted by our work, we strive to create a sense of inclusion and belonging. We are looking for self-motivated, creative problem solvers who are excited by the idea of working in a fast-paced start-up environment and contributing to our growth.

Since 1972, Windmill has been the trusted source for quality, innovative and efficacious vitamins and supplements. We offer numerous products in a variety of categories and delivery systems, so customers can feel confident to rely on us to support their overall well being. Windmill products are available in multiple outlets nationwide. Learn more about what we can do for you. Windmill’s numerous and sustainable array of health products satisfies a variety of market needs, including multi and single vitamins and minerals, whole food supplements, greens, proteins, specialty formulas, anti-aging nutrition, condition specific, performance nutrition, and herbals. Our first-to-market products are available in numerous delivery systems, including: tablets, capsules, softgels, chewables, powders, liquids, gummies, chews, instant melts, and topicals. We also offer a variety of packaging options, such as bottles, blister cards, cans, packets, pouches, and individual serving containers; all with unique designs. Windmill is one of the few, true single source VMS distributors with its own products sold nationwide and internationally to over 150,000 retailers, including: independent pharmacies, chain drug, grocery, mass market, warehouse clubs, convenience, specialty/health food and discount stores; plus catalog, web, government and military. Our strong and enduring relationships with retailers demonstrate our exceptional service and qualifications. Today, 75% of the U.S. adult population uses vitamins or nutritional supplements to strive for wellness. Individuals also supplement daily to fill nutrient gaps in their diet and enhance energy levels to keep up with their hectic lifestyles. VMS intake has increased in the last decade and continues to grow each year. Consumer awareness, scientific studies, positive media, mass market distribution, and the aging U.S. population have substantially contributed to this growth. Windmill has provided quality nutritional suppl

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include PEMFEXY®, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM® (Japan), and Byfavo® and Barhemsys® through its wholly owned subsidiary Acacia Pharma Inc. Eagle’s oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.

A global specialty additive supplier offering defoamers for reducing the problems associated with foam formation in the production and application of water-based systems. Munzing's product lines include: DEE FO® and AGITAN® - defoamers for printing inks, coatings and adhesives; EDAPLAN® - leveling and universal dispersing agents; METOLAT® - wetting agents; TAFIGEL® - rheology modifiers; CERETAN - micronized and coated waxes; LUBA-print - wax dispersions. For industrial applications, our FOAM BAN® products are formulated for specific levels of foam control unique to each application, from metalworking fluids and industrial cleaners to antifreeze coolants and industrial lubricants. Our MAGRABAR® product line has been developed for a wide range of applications in the food industry. We offer both liquid and powder products in a range of materials and concentrations, including options suitable for organic, non-GMO and identity preserved processing. Our organic products are certified by QAI, and non-GMO options are Non-GMO Project Verified. If you have a specific foaming challenge, we have the technical expertise and laboratory capabilities to craft a unique solution.

Pharmacosmos Therapeutics Inc., an affiliate of Pharmacosmos, markets Monoferric in the US high-dose IV iron market. Pharmacosmos Therapeutics brings together: - A best-in-class product - Resources required to drive rapid growth - An ability to adapt quickly to market change - A new standard for patient care Founded in 1965, Pharmacosmos headquarters in Denmark. We are a family-held company built on passionate and knowledgeable people. We value integrity, open-mindedness, and respect. These values guide us in our endeavors and touch everyone in every part of our journey. We respect everyone who becomes a part of our journey. As a company , we strive to become the world leader in the treatment of iron deficiency anemia, one of the largest global health issues, and aspire to change the way iron deficiency anemia is treated. Pharmacosmos is focused on three business areas: branded pharmaceuticals, APIs, and carbohydrates. The US company focuses primarily on the prescription iron pharmaceutical market. Two-thirds of its revenue comes from this segment of the business. Pharmaceutical grade carbohydrates and API enhance their supply chain capabilities and overall market strategy and positioning. The company takes pride in our robust research and development program with a focus on human and veterinary medicines. Pharmacosmos cultivates a collaborative, performance-based culture. We recognize and reward employees for the value they bring and empower them to do meaningful work. Built upon the heritage and financial strength of the parent company, Pharmacosmos Therapeutics benefits from a singular focus, driving the growth of Monoferric.

Bruno Bock (formerly known as Evans Chemetics) is a chemicals company based out of 500 Frank W Burr Blvd, Teaneck, NJ, United States.

Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2022 amounted to SEK 624 million, and the number of employees to 126. Orexo is listed on Nasdaq Stockholm's main list and is available as an ADR on OTCQX (ORXOY) in the US. For more information about Orexo please visit, www.orexo.com. You can also follow Orexo on LinkedIn, X and YouTube.

Wockhardt Limited created its US subsidiary Wockhardt USA in early 2004 with a modest portfolio of three FDA–approved generic products. Since inception, Wockhardt’s business has increased in the US. Today, Wockhardt USA LLC is leading the way in developing the most complete, high-quality line of generic oral solids, liquids, topicals, and injectables available in the United States. Wockhardt USA now represents more than 20% of Wockhardt Ltd’s global business, providing more than 220 NDCs spanning more than 75 different product families. We have been producing and distributing quality products in the United States for more than 14 years and have received over 110 ANDA approvals to date. Chicago-based Morton Grove Pharmaceuticals was acquired by Wockhardt Limited in October 2007 in order to expand Wockhardt’s product line in the US. Since 1995, Morton Grove has been a leading manufacturer and marketer of oral liquid and topical pharmaceuticals. The company’s core products are manufactured in its 125,000 square foot, state-of-the-art facility.